You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

The Utility of Positron Emission Tomography in Epilepsy

ID: PET 13 Jan 2015
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
J.G. Burneo, R. Poon, S. Kellett, S. Houle, O.C. Snead, Ontario PET Steering Committee

Guideline Objective

In response to several requests for PET in the presurgical planning of patients with medically intractable epilepsy through the Ontario PET Access Program, a systematic review of the literature was conducted to provide potential recommendations for the use of 18F-FDG PET in this indication.

Patient Population

Adult and pediatric patients with medically intractable epilepsy being considered for surgery.

Intended Guideline Users

To guide the Ontario PET Steering Committee in their decision making with respect to the development of indications for the use of PET in epilepsy. This recommendation report may also be useful to inform clinicians who are seeking information about PET as a presurgical tool in epilepsy.

Research Question(s)

What is the diagnostic accuracy and clinical utility of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in the presurgical evaluation of adult and pediatric patients with medically intractable epilepsy?

pdf download Summary (PDF) (36.84 KB)
pdf download Full Report (PDF) (511.48 KB)